743470
Last Update Posted: 2010-11-02
Recruiting has ended
All Genders accepted | 18 Years-55 Years |
15 Estimated Participants | No Expanded Access |
Interventional Study | Accepts healthy volunteers |
A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects
The purpose of this study is to study the safety, tolerability and pharmacokinetics of rifabutin dosing with lopinavir/ritonavir tablets in healthy volunteers.
Eligibility
Relevant conditions:
HIV
Tuberculosis
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov